SHANGHAI, China, July 8 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (OTC Bulletin Board: CHBT) ("China-Biotics," "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced Dr. Shuguang Fang, China-Biotics' Chief Technology Officer, has been invited to be the guest speaker at China's 3rd Annual Food Safety Technology Forum 2008 (the "Forum").
The Forum, organized by Ringier Trade Publishing Ltd., will be held July 8-9, 2008, at the Renaissance Shanghai Pudong Hotel in Shanghai, China. Dr. Fang will address the topic of "Probiotics Safety in Dairy Products" on Wednesday, July 9.
"We are honored to share our expertise in the application of probiotics as bulk additives with all the related parties at the Forum," said Mr. Jinan Song, China-Biotics' Chairman and Chief Executive Officer. "Both the Chinese government and the Chinese public place great importance on food safety technology, as the standard of living continues to improve in China. We anticipate that the demand for probiotics as bulk additives will increase substantially once consumers realize the benefits and trust the safety of this technology."
The Forum will present an integrated approach to the safety and management of milk and dairy products, functional beverages, beer and alcohol, convenience foods and meat, poultry and fish products. For more information, please visit http://www.industrysourcing.com/English/web/Detail.aspx?conferenceid=32 .
About Ringier Trade Publishing Ltd
Ringier Trade Publishing Ltd. is the Hong Kong-based subsidiary of Ringier AG, the Swiss multimedia communications group founded in Zurich in 1831. Ringier publishes 26 specialized industry magazines for China, in simplified Chinese, reaching more than 560,000 decision-makers in China's chemical processing and metalworking industries, three bilingual Chinese-English trade magazines for Asia and23 technology conferences. These publications are supported by a traditional Chinese, simplified Chinese and English sourcing site, http://www.industrysourcing.com .
About China-Biotics, Inc.
Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics", "the Company") was founded in 1999 and is one of China's largest suppliers of probiotics. Probiotics are beneficial live bacteria used as dietary supplements and food additives to improve intestinal health and digestion. The Company's product portfolio contains live microbials made with proprietary technology. Currently, these products are sold over-the-counter under the "Shining" brand through large distributors to more than 1,000 pharmacies and 100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the most recognized brands in Shanghai. China-Biotics plans to expand its retail sales to other major cities in China and is launching 300 Shining brand logistic centers in these cities. The Company's flagship product, "Shining Essence", has been a profit driver since its launch in April 2001. There is a significant demand for probiotics for use in the bulk additive market, which is currently met by imports. China-Biotics is building a new plant which will increase its production capacity manifolds to capture this market. For more information, please visit http://www.chn-biotics.com .
Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company's ability to market existing and new products, ability to access capital for expansion, changes from anticipated levels of sales, future national or regional economic and competitive conditions, changes in relationships with customers, dependence on its flagship product profits and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future events or otherwise.
For more information, please contact:
CCG Investor Relations
Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
Email: crocker.coulson@ccgir.com
Web: http://www.ccgir.com
